Group 1: Strategic Planning and Business Development - The company aims for high-quality development by focusing on both medical and consumer goods sectors, with a strategic theme of "product leadership, excellent operations, brand enhancement, and digital empowerment" for 2026 [1] - The company plans to enhance profitability through product innovation, optimizing product structure, and improving channel management [2] - The company emphasizes long-term development and aims to return stable dividends to shareholders [2] Group 2: Investment Highlights - The core investment value is based on five aspects: broad industry space, significant brand and product advantages, stable financial status, consistent dividend policy, and a commitment to long-term sustainable development [3] - The company maintains a low debt-to-asset ratio and has robust operating cash flow, ensuring financial safety [3] Group 3: Medical Sector Growth Drivers - The medical sector's growth strategy for 2026 focuses on "product leadership" and includes three key battles: product breakthroughs, channel expansion, and integration with newly acquired companies [4] - The company plans to enhance product value and expand overseas markets while achieving revenue growth targets set by equity incentives [4] Group 4: Overseas Business Development - The company has established a solid foundation in overseas markets, including Europe, Japan, South Korea, and Southeast Asia, and aims to enhance brand sales and market presence [5] - The focus will be on clinical and academic promotion, particularly in Southeast Asia and the Middle East, with significant investments in market education [5] Group 5: Product Planning for All-Cotton Era - In 2026, the All-Cotton Era will focus on six key areas: maternal and infant care, personal care, intimate apparel, home sleep products, outdoor clothing, and light sports [6] - The strategy emphasizes the core advantages of "cotton philosophy, quality genes, and medical background" to strengthen brand recognition [6] Group 6: Retail Strategy and Store Efficiency - The All-Cotton Era plans to enhance store quality and efficiency through existing store optimization and cautious new store openings [7] - Key initiatives include upgrading store images, enhancing membership services, and embracing new retail channels for integrated online and offline experiences [8] Group 7: Dividend Policy - The company prioritizes shareholder returns, maintaining annual cash dividends, with cumulative cash dividends reaching CNY 2.88 billion by mid-2025 [9] - Future dividend levels will be assessed based on annual profits, growth potential, and strategic development plans [9] Group 8: R&D and Competitive Advantages - The company adheres to a "product leadership" strategy, focusing on innovation and high-quality product development in both medical and consumer sectors [10] - As of mid-2025, the company holds 1,109 patents in medical consumables and 701 medical product registration certificates, ensuring a leading position in the industry [10]

Group 1 - The company plans to hold a "Thanksgiving Shareholder Event" from September 17 to October 8, 2025, to celebrate its fifth anniversary of listing [1] - The event is aimed at all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shenzhen Branch as of the market close on September 16, 2025 [1] - Eligible shareholders can obtain exclusive benefit vouchers after identity verification, allowing them to purchase company products at discounted prices during the exclusive shareholder appreciation event [1]